TRAF1 and TRAF2 form a heterodimer.
Since the NFκB pathway is so essential and there are many proteins involved in these cascades, several diseases have been found in patients related to it (for a review see 4). There are PIDs among these diseases, namely Xlinked hyper IgM syndrome and hypohydrotic ectodermal dysplasia due to mutations in NEMO (IKBKG) (5), and autosomal dominant anhidrotic ectodermal dysplasia and Tcell immunodeficiency because of IKKα (NFKBIA) (6) mutations. Both these proteins are subunits of the IKK complex. IRAK4 deficiency arises from impaired IRAK4 function (7). Along with IRAK1, one of our PID candidates, it participates in IL1 receptor and Tolllike receptor (TLR) pathways. Information for disease causing mutations in these genes and other PID genes is available from IDbases (8).
Other PID candidates with signaling functions include Fyn, a Src family PTK, and MAPK14, a MAP family serine/threonine kinase. The Src and MAP kinase families are both very essential signaling routes that regulate various activities within cells. Knockout mouse model for Fyn shows several defects in Tcell development and function (9,10). Soluble and receptor kinases are often cancercausing when mutated. Both inactivating and constitutively activating gainoffunction mutations can be deleterious.
Insulinlike growth factor 1 receptor (IGF1R) is another PTK. It recognizes IGF1, which is a polypeptide hormone and similar to insulin, which binds to another PID candidate, insulin receptor (INSR), another receptor PTK. INSR is the causative gene for diabetes mellitus, an autoimmune disease. Our method selects it because the patients could also have PID symptoms which, however, are usually hidden because of diabetes. Again, there is a possibility that some patients might also have PID symptoms.
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Tyrosine kinase 2 (TYK2) belongs to the same family as Janus kinase 3 (JAK3), which leads to SCID when mutated (11,12), and JAK1 and JAK2, which are also PID candidates. The family members are involved in cytokine receptor signaling pathways. They exert their function by phosphorylating STAT family member proteins, which form homo and heterodimers. The dimers are then translocated to the nucleus to act as transcription activators. STAT1 and 2 cause PID when mutated (13) and STAT3 is a PID candidate (14) .
The importance of these pathways is further indicated by suppressor of cytokine signaling 1 Some of the candidate genes are so essential that it is likely that mutations in them have lethal effects and therefore may not appear in PID patients. For example, deletion of the Fas associated death domain (FADD) gene causes embryonic lethality in mice (17, 18) . In platelet derived growth factor receptor, beta polypeptide (PDGFRB) mutations cause perinatal 5/9 lethality (19) .
Estimation of the performance of the method Our bioinformatics method can prioritize possible candidate genes. Accurate estimation of selectivity and specificity of the method cannot be done because of lack of a test set. We can roughly estimate the performance as follows: The high network scores together with the significant gene ontology terms resulted in 39 genes (Fig. 2) . 13 of them were known PID genes. When extrapolating based on this ratio we expect at least 8 to 9 genes of the predicted 26 to have a connection to PIDs. This ratio is somewhat higher than the 10% estimated for some earlier methods (20) . Recently some methods have been reported to have higher selectivity, around 2040% (21, 22) . These methods restrict the search space and require the chromosomal location of the disease gene to be known. Our approach does not need or use this kind of information and is thus a true de novo candidate prediction method.
